MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma
- PMID: 20128019
- PMCID: PMC2816263
- DOI: 10.3748/wjg.v16.i5.531
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma
Abstract
Barrett's esophagus is a premalignant condition caused by gastroesophageal reflux. Once developed, it can progress through varying grades of dysplasia to esophageal adenocarcinoma. Whilst it is well accepted that Barrett's esophagus is caused by gastroesophageal reflux, the molecular mechanisms of its pathogenesis and progression to cancer remain unclear. MicroRNAs (miRNAs) are short segments of RNA that have been shown to control the expression of many human genes. They have been implicated in most cellular processes, and the role of miRNAs in disease development is becoming increasingly evident. Understanding altered miRNA expression is likely to help unravel the molecular mechanisms that underpin the development of Barrett's esophagus and its progression to cancer.
Similar articles
-
Risk factors for neoplastic progression in Barrett's esophagus.World J Gastroenterol. 2011 Aug 28;17(32):3672-83. doi: 10.3748/wjg.v17.i32.3672. World J Gastroenterol. 2011. PMID: 21990948 Free PMC article. Review.
-
[Carcinogenesis of Barrett's esophagus].Nihon Rinsho. 2005 Aug;63(8):1357-61. Nihon Rinsho. 2005. PMID: 16101221 Review. Japanese.
-
Risk factors, DNA damage, and disease progression in Barrett's esophagus.Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5. doi: 10.1158/1055-9965.EPI-04-0509. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767340
-
MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.Cancer Prev Res (Phila). 2013 Mar;6(3):196-205. doi: 10.1158/1940-6207.CAPR-12-0276. Cancer Prev Res (Phila). 2013. PMID: 23466817 Free PMC article.
-
Gastroesophageal reflux disease: From heartburn to cancer.World J Gastroenterol. 2010 Aug 14;16(30):3743-4. doi: 10.3748/wjg.v16.i30.3743. World J Gastroenterol. 2010. PMID: 20698034 Free PMC article.
Cited by
-
Salivary microRNAs as promising biomarkers for detection of esophageal cancer.PLoS One. 2013;8(4):e57502. doi: 10.1371/journal.pone.0057502. Epub 2013 Apr 1. PLoS One. 2013. PMID: 23560033 Free PMC article.
-
MicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux.BMC Res Notes. 2011 Feb 27;4:41. doi: 10.1186/1756-0500-4-41. BMC Res Notes. 2011. PMID: 21352563 Free PMC article.
-
miRNA-221 and miRNA-483-3p Dysregulation in Esophageal Adenocarcinoma.Cancers (Basel). 2024 Jan 30;16(3):591. doi: 10.3390/cancers16030591. Cancers (Basel). 2024. PMID: 38339342 Free PMC article.
-
miR-203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5.Tumour Biol. 2016 Dec;37:15989–15995. doi: 10.1007/s13277-016-5438-7. Epub 2016 Oct 6. Tumour Biol. 2016. PMID: 27714672
-
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.J Allergy Clin Immunol. 2012 Apr;129(4):1064-75.e9. doi: 10.1016/j.jaci.2012.01.060. Epub 2012 Mar 3. J Allergy Clin Immunol. 2012. PMID: 22391115 Free PMC article.
References
-
- Jenkins GJ, Doak SH, Parry JM, D'Souza FR, Griffiths AP, Baxter JN. Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma. Br J Surg. 2002;89:824–837. - PubMed
-
- Shaheen NJ, Richter JE. Barrett's oesophagus. Lancet. 2009;373:850–861. - PubMed
-
- Gillen P, Keeling P, Byrne PJ, Healy M, O'Moore RR, Hennessy TP. Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. Br J Surg. 1988;75:540–543. - PubMed
-
- Souza RF, Krishnan K, Spechler SJ. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol. 2008;295:G211–G218. - PubMed
-
- Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical